BCMA Targeted Therapies
Evvnt Promotion / evvnt
Archivio
12.07.2022 - 14.07.2022 The Bostonian, 26 North Street, 02109 Boston, Massachusetts, USA
Time: 9:00 AM - 4:30 PM
Temi della conferenza
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/1093163-2?pid=4832
Mr. Hanson Wade
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
